Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions
- 1 January 2001
- journal article
- Published by Elsevier BV in Lung Cancer
- Vol. 31 (1), 9-16
- https://doi.org/10.1016/s0169-5002(00)00153-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinomaRespiratory Medicine, 1997
- Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid: A study of 207 patientsCancer, 1996
- Assessment of serum CYFRA 21-1 in lung cancerCancer, 1996
- CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusionsEuropean Respiratory Journal, 1996
- Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screeningCancer, 1993
- Tumour associated antigens in diagnosis of serous effusions.Journal of Clinical Pathology, 1988
- Detection of malignant pleural effusions by tumor marker evaluationEuropean Journal of Cancer and Clinical Oncology, 1988
- The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignanciesEuropean Journal of Cancer and Clinical Oncology, 1985
- Carcinomatous and Tuberculous Pleural EffusionsChest, 1985
- Serum sialic acid levels in health and diseaseJournal of Clinical Pathology, 1962